Results 151 to 160 of about 35,016 (265)

Reprogramming the Immune Landscape of Inflammatory Breast Cancer

Advanced Science, Volume 13, Issue 36, 29 June 2026.
Inflammatory breast cancer is the most lethal subtype of breast cancer and is characterized by an immunosuppressive tumor microenvironment (TME) driven by a complex network of immune cells and inflammatory cytokines, contributing to its aggressiveness and treatment challenges. Immune checkpoint inhibitors, either alone or in combination, show potential
Verena Martinez‐Rodriguez, Suguru Ogata, Xiaoping Wang, Naoto T. Ueno   +3 more
wiley   +1 more source

Prediction of lymphovascular invasion in rectal cancer based on multimodal magnetic resonance imaging radiomics model. [PDF]

World J Gastrointest Surg
Zhu ZH, Liang Y, Shi M.
europepmc   +1 more source

Comprehensive Genomic Profiles of Patients With Biliary Tract Cancer

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Purpose Biliary tract cancer (BTC) represents a heterogeneous disease with highly lethal malignancy and poor clinical outcomes. Here, we aimed to evaluate its genomic profiles to promote the development of precision medicine for BTC. Materials and Methods Genomic analysis of 134 BTC patients was performed by using targeted panel sequencing in ...
Xia Yang, Tao Zhu, Xiaotong Hu, Zhinong Jiang, Hongchuan Jin   +4 more
wiley   +1 more source

Cribriform Tumor Burden in Grade Group 4 Prostate Cancer: A Quantitative Threshold Predicting Lymphovascular Invasion and Metastasis. [PDF]

J Clin Med
Tosun I, Sahin O, Kucuk EV.
europepmc   +1 more source

Endometrial Cancer of the Uterine Isthmus: A Cohort Study on Clinicopathological Features and Prognosis

Cancer Medicine, Volume 15, Issue 6, June 2026.
The study compared the clinicopathologic characteristics and prognosis of patients with uterine isthmus cancer to those with uterine fundus cancer. The aim was to identify risk variables associated with the prognosis of patients with isthmus cancer. Uterine isthmus cancer demonstrates a higher stage, a stronger tendency for adjuvant therapy, and a more
Hao Wang, Peijie Xiao, Chendi Zhu, Jinxia Zhou, Chunhua Yang, Paulo Moreira, Li Yan   +6 more
wiley   +1 more source

Integrated PET-IVIM-DKI MRI for predicting lymphovascular invasion in NSCLC. [PDF]

Insights Imaging
Chen Q, Meng N, Li D, Liu X, Wu Y, Yang Y, Huang Z, Wang Z, Wang M, Fu F.   +9 more
europepmc   +1 more source

MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Objective This study aimed to develop and validate an MRI‐based DeltaHabitat radiomics model to predict pathological complete response (pCR) in oral cavity squamous cell carcinoma (OCSCC) patients treated with neoadjuvant chemoimmunotherapy. Methods Patients treated with neoadjuvant chemoimmunotherapy and surgery were retrospectively included ...
Lin Ding, Jialing Wu, Yangxin Liang, Jiaxuan Ding, Shu Zhou, Liting Li, Lehang Lin, Jiale Zeng, Changlong Chen   +8 more
wiley   +1 more source

Pre-Treatment BOC Expression as an Indicator of Lymphovascular Invasion and <i>In Vitro</i> Chemotherapeutic Response in Upper Tract Urothelial Carcinoma. [PDF]

Oncol Res
Chang YL, Luo HL, Peng JM, Hsiao CC.
europepmc   +1 more source

A Case of Clear Cell Papillary Renal Cell Tumor: A Rare Entity With an Unusual Presentation

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Clear cell papillary renal cell Tumor (CCPRCT) is a rare variant of renal cell carcinoma that typically arises in a nonfunctional kidney. We report a case of CCPRCT in a 49‐year‐old Iranian male who presented with a mural nodule within a large cystic mass in his nonfunctional left kidney, and we discuss the relevant diagnostic challenges ...
Mehdi Montazer, Naser Tayyebi Meibodi, Salman Soltani, Sarvin Beigi   +3 more
wiley   +1 more source

Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size. [PDF]

BMC Cancer
Çelik S, Kavak EE, Dilli İ, Zeynelgil E, Sevim HA, Rahatlı S, Eren T.   +6 more
europepmc   +1 more source